The addition of a specific IRA inhibitor would be required to overcome this, as nonspecific IR inhibitors (e.g., the compound S961) and IGF1R tyrosine kinase inhibitor small molecules cause hyperglycemia and compensatory hyperinsulinemia [18,65]. This evidence concerns the gene IGF1R and Hyperglycemia.